The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Palonosetron Hydrochloride · PALONOSETRON HYDROCHLORIDE .25 mg/5mL · Injection, Solution · Intravenous · Mylan Institutional LLC
NDC 67457-0317-25 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Eugia US LLC | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | PALONOSETRON HYDROCHLORIDE .05 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Parenteral Medicines, Inc. | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Aug 31, 2026 |
| Avenacy, Inc. | PALONOSETRON HYDROCHLORIDE .05 mg/mL | Jul 15, 2026 | Aug 5, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Palonosetron Hydrochloride — NDC 67457-0317-25," retrieved September 3, 2026, https://drugdashboards.com/drug/67457031725.
Free to cite with attribution — see how the data is put together.